| Name | Title | Contact Details |
|---|---|---|
Caroll Casbeer |
Head of Growth Marketing | Profile |
Michael Gephart |
Vice President, Sales and Business Development | Profile |
Tim Wagner |
Co-Founder, Chief Executive Officer | Profile |
Nortal is a leading digital transformation company. Combining the unique experience of transforming Estonia into a digital leader and creating change in businesses with a strategic approach and data-driven technology, our vision is to deliver the future. Seamlessly. Nortal operates from 18 offices in 10 countries and employs 1000+ specialists who carry out high-impact projects across Europe, the Nordics, the GCC region and the U.S.
Hero Digital is a leading independent customer experience company born in California at the intersection of business, design, and technology. Our purpose is to distill the simple truth to create a beautiful future — a customer experience future that is good for people and business. Hero Digital`s holistic process and integrated methods help leading brands like Comcast, Twitter, U.S. Bank, Salesforce, Sephora, Jefferson Health, The Robert Wood Johnson Foundation, and TD Ameritrade Institutional achieve growth. We have been named one of Adweek`s Fastest Growing Agencies and one of Inc.`s hottest companies. Our growth is both rapid and thoughtful, with a commitment to diversity and inclusion. We welcome the contributions and perspectives of people from every race, gender, religion, background, and identity.
UNI Data Inc. is a Fredericton, NB-based company in the Computers & Electronics sector.
EPS Corporation is a Eatontown, NJ-based company in the Computers and Electronics sector.
Episource provides a complete and integrated set of services and products to simplify the way Medicare, Commercial and Medicaid health plans manage their risk adjustment and quality programs. We work with health plans and healthcare organizations to absorb the most challenging aspects of program implementation, operations, and management. We simplify by modernizing workflows to better assess the full cycle of Risk Adjustment and Quality programs to improve clinical outcomes and financial performance.